CHIKV Replicon Stable BHK Cell Line

Description

The CHIKV-NCT replicon cell system is a stable BHK cell line derived from the LR2006 OPY1 strain of Chikungunya virus, designed for safe, BSL-2 compatible antiviral research. It carries a non-cytotoxic replicon encoding Renilla luciferase and an EGFPpuromycin cassette, enabling real-time monitoring, quantitative readouts, and drug selection without handling infectious virus. This platform is ideal for high-throughput screening and mechanistic studies of CHIKV replication and inhibition.